Venrock Healthcare Capital Partners III, L.P.
Insider
- 2026
- Mar 27, 2026
- 1
Summary
Latest filing:
Venrock Healthcare Capital Partners III, L.P. files SEC Form 4 reports at KalVista Pharmaceuticals, Inc. (KALV). 1 SEC Form 4 filing on record, dated 27 March 2026. Most recent open-market trade: sold $61K of KALV on 27 March 2026. Lifetime open-market sales: $3.69M.
Recent transactions
5The latest 5 SEC Form 4 transactions reported by Venrock Healthcare Capital Partners III, L.P..
Trading pattern
InsiderAlpha's records for Venrock Healthcare Capital Partners III, L.P. go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Venrock Healthcare Capital Partners III, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Yea - $1.23M in KALV purchases and sales in the last 12 months
- Benjamin L. Palleiko - $1.19M in KALV purchases and sales in the last 12 months
- Paul K. Audhya - $430K in KALV purchases and sales in the last 12 months
- Nicole Sweeny - $241K in KALV purchases and sales in the last 12 months
- Brian Piekos - $165K in KALV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Venrock Healthcare Capital Partners III, L.P.?
Venrock Healthcare Capital Partners III, L.P. is an investment firm of KalVista Pharmaceuticals, Inc. (KALV). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Venrock Healthcare Capital Partners III, L.P. last file a Form 4?
The only primary Form 4 on record is dated 27 March 2026.
Has Venrock Healthcare Capital Partners III, L.P. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($3.69M) across all tracked filings.